Zhuhai Rundu Pharmaceutical (002923.SZ) released the quarterly report for the first three quarters of 2024, during the reporting period the company achieved revenue...
According to the Zhitong Finance and Economics APP, Zhuhai Rundu Pharmaceutical (002923.SZ) released the quarterly report for the first three quarters of 2024. During the reporting period, the company achieved revenue of 0.877 billion yuan, a decrease of 7.23% year-on-year; the net income attributable to shareholders of the listed company was 37.1805 million yuan, a decrease of 43.29% year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 26.1212 million yuan, a decrease of 45.43% year-on-year; and the basic earnings per share was 0.11 yuan per share.
